Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 2 of 2
Full-Text Articles in Life Sciences
Porphyrin Derivatives And Photodynamic Therapy Effects On Triple Negative Breast Cancer, Sarah Rogers, Joseph E. Bradshaw, Timothy E. Hayes
Porphyrin Derivatives And Photodynamic Therapy Effects On Triple Negative Breast Cancer, Sarah Rogers, Joseph E. Bradshaw, Timothy E. Hayes
Scholars Day
There are limited effective options for treatment of triple negative breast cancer (TNBC) due to its lack of the three receptors typically used to target breast cancer. The use of photodynamic therapy (PDT) to kill cells that take up light-absorbing compounds (PDT agents) may be an effective option to treat TNBC. We tested the efficacy of modified porphyrins as PDT agents against cells from TNBC. We compared these to Foscan, which is similar in structure to porphyrins and has been approved for use in Europe. Our 1st goal was to measure which porphyrins were taken up best by TNBC cells. …
Thrilling Monotony: A Summer Of Alzheimer's Research, Baronger Dowell Bieger
Thrilling Monotony: A Summer Of Alzheimer's Research, Baronger Dowell Bieger
Honors Theses
The primary genetic risk determinant for late-onset Alzheimer's disease is the apolipoprotein E gene (APOE). Variations in this gene produce three different isoforms of the apolipoprotein E protein (ApoE): ApoE2, ApoE3, and ApoE4. ApoE# is the most common isoform, so rates of LOAD among other genotypes are indexed to this variant. ApoE2 is rather rare, but its carriers are less likely to get LOAD; when they do, they get it later. The second most common variant is ApoE4, and its carriers are significantly more likely to get LOAD. They also tend to succumb earlier. Once developed, LOAD is characterized by …